Elekta AB
EKTA B
ISIN SE0000163628 / Valor 613625
Elekta AB
UMushroom community rating:
About company
Elekta AB is a global company that provides innovative solutions and AI-supported services to clinicians, enabling them to treat more patients with higher quality. The company's offerings are designed to improve patient outcomes and enhance the efficiency of healthcare providers. Elekta AB leverages its global network to deliver value-creating innovations in the field of medical technology, particularly in the areas of radiation therapy and radiosurgery. With a focus on cutting-edge technology and customer service, Elekta AB plays a crucial role in advancing healthcare worldwide.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (11.10.2025):
Elekta AB reported its financial results for the first quarter of 2025/26, demonstrating steady performance with growth in net sales and significant improvements in net income despite challenges from foreign exchange and tariff costs.
Net Sales
Net sales increased by 3% in constant exchange rates, driven primarily by strong performance in Europe. However, reported sales declined by 5% to SEK 3,646 million compared to SEK 3,825 million in the same period last year.
Book-to-Bill Ratio
The book-to-bill ratio was 1.05, slightly down from 1.10 in the previous year, supported by continued strong order growth for the Elekta Evo system.
Adjusted Gross Margin
The adjusted gross margin decreased to 37.0% from 37.8% year-over-year, primarily due to adverse foreign exchange effects and increased tariff costs, which together impacted the margin by 190 basis points.
Adjusted EBIT
Adjusted EBIT was SEK 235 million, a decrease from SEK 283 million in the prior year, resulting in a margin of 6.5% compared to 7.4% previously.
Net Income and Earnings Per Share
Net income rose by 50% to SEK 106 million from SEK 71 million. Earnings per share before and after dilution increased to SEK 0.28 from SEK 0.18.
Cash Flow
Cash flow after continuous investments improved significantly by SEK 529 million year-over-year, reaching SEK -361 million compared to SEK -891 million in the first quarter last year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1629 M
Market cap (USD)
754,978
Daily traded volume (Shares)
61.25 / 60.25
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
